Montes Archimedes Acquisition Corp. (MAAC)

Home » Stocks » Montes Archimedes Acquisition

Montes Archimedes Acquisition currently trades with the ticker symbol MAACU

Stock Price: $9.89 USD 0.00 (0.00%)

Updated Oct 20, 2020 4:00 PM EDT - Market closed

• Overview
• News
• Chart

Key Info

Market Cap	494.50M
Revenue (ttm)	n/a
Net Income (ttm)	n/a
Shares Out	52.50M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Dividend Yield	n/a

Stock Quote

Trading Day	Oct 20, 2020
Last Price	$9.89
Previous Close	$0.00
Change ($)	0.00
Change (%)	0.00%
Day's Open	9.92
Day's Range	9.89 - 9.92
Day's Volume	154,594
52-Week Range	0.00 - 9.92

More Stats

Market Cap	494.50M
Enterprise Value	n/a
Earnings Date (est)	n/a
Ex-Dividend Date	n/a
Shares Outstanding	52.50M
Float	n/a
EPS (basic)	n/a
EPS (diluted)	n/a
FCF / Share	n/a

Dividend	n/a
Dividend Yield	n/a
Earnings Yield	n/a
FCF Yield	n/a
Payout Ratio	n/a
Shares Short	n/a
Short Ratio	n/a
Short % of Float	n/a
Beta	n/a

PE Ratio	n/a
Forward PE	n/a
P/FCF Ratio	n/a
PS Ratio	n/a
PB Ratio	n/a
Revenue	n/a
Operating Income	n/a
Net Income	n/a
Free Cash Flow	n/a

Net Cash	n/a
Net Cash / Share	n/a
Gross Margin	n/a
Operating Margin	n/a
Profit Margin	n/a
FCF Margin	n/a
ROA	n/a
ROE	n/a
ROIC	n/a

Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy	0
Overweight	0
Hold	0
Underweight	0
Sell	0

What these ratings mean

Analyst Consensus: n/a

Price Target

$n/a*

*No analysts have provided price targets for this stock.

Financial Overview

No financial data available for this stock yet.

Company Profile

Company Details

Full Name	Montes Archimedes Acquisition Corp.
Country	United States
CEO	James C. Momtazee

Stock Information

Ticker Symbol	MAAC
Stock Exchange	NASDAQ
Industry	Blank Checks / SPAC
Unique Identifier	NASDAQ: MAAC
IPO Date	October 7, 2020

Description

Montes Archimedes Acquisition Corp is a newly incorporated blank check company incorporated in July 2020 as a Delaware corporation whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We will seek to capitalize on the more than 50 years of combined investing experience of our Founders, James C. Momtazee and Maria C. Walker. We believe our Founders' distinctive and complementary backgrounds can have a transformative impact on a target business. Although we may pursue targets in any business industry or sector, we intend to focus our investment efforts broadly across the entire health care industry, which encompasses among other things technology-enabled services, biopharmaceuticals, pharmaceutical value chain, medical devices, diagnostics, providers, digital health and consumer health. Investment opportunities will be sourced through the Founders' proprietary and differentiated network built over decades of investing in and growing health care businesses. The company will employ a disciplined and highly selective investment process that focuses on accessing differentiated opportunities through deep relationships with executives, advisors, and intermediaries to enhance the growth potential and value of a target business and provide opportunities for an attractive return to our shareholders.